DCF — EUCLID HOSPITAL
Enterprise Value: $-233.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-233.1M
Enterprise Value
$-72.5M
PV of Cash Flows
$-160.6M
PV of Terminal Value
$-258.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $109.5M | $-15.2M | -14.0% | $-19.8M | $-18.0M |
| Year 2 | $112.7M | $-14.5M | -13.0% | $-19.3M | $-15.9M |
| Year 3 | $116.1M | $-13.8M | -12.0% | $-18.7M | $-14.1M |
| Year 4 | $119.6M | $-13.6M | -11.0% | $-18.7M | $-12.8M |
| Year 5 | $123.2M | $-13.7M | -11.0% | $-18.9M | $-11.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-233.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$106.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1438065589874906
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5